Dr Tanya Soboleva tells about the unique histone H2A.B and a new hope for Hodgkin lymphoma treatment

Researchers at The Australian National University have discovered how a DNA-binding protein sustains Hodgkin lymphoma. Lead researcher Dr Tanya Soboleva, from the ANU John Curtin School of Medical Research, said the discovery could hold the key to better health outcomes for thousands of patients globally.

Dr Tanya Soboleva in the Lab. Source: Supplied by T.Soboleva